Accessibility Menu
 
Innovation1 Biotech logo

Innovation1 Biotech

(OTC) IVBT

Current Price$0.00
Market Cap$4,500
Since IPO (2017)-100%
5 Year-100%
1 Year-75%
1 Month+0%

Innovation1 Biotech Financials at a Glance

Market Cap

$4,500

Revenue (TTM)

$104.87K

Net Income (TTM)

$5.30M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

1.00 (Low)

Price

$0.00

Volume

7

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

IVBT News

No articles available.

IVBT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Innovation1 Biotech

Industry

Pharmaceuticals

Employees

5

CEO

Frederick E. Pierce, II

Headquarters

Somerville, NY 10005, US

IVBT Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

43%

Return on Assets

-79%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.50K

Shares Outstanding

22.47M

Volume

7

Short Interest

0.00%

Avg. Volume

1.35

Financials (TTM)

Gross Profit

$52.70K

Operating Income

$1.37M

EBITDA

$5.68M

Operating Cash Flow

$620.20K

Capital Expenditure

$5.00

Free Cash Flow

$620.20K

Cash & ST Invst.

$49.85K

Total Debt

$229.00K

Innovation1 Biotech Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

$261.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$4.50K

N/A

Market Cap/Employee

$4.50K

N/A

Employees

1

N/A

Net Income

$290.00K

+51.9%

EBITDA

$149.74K

+73.5%

Quarterly Fundamentals

Name
Q2 2024YOY CHG

Net Cash

$497.54K

-2573.6%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$555.06K

+2382.2%

Short Term Debt

$50.00K

+400.0%

Return on Assets

-78.80%

N/A

Return on Invested Capital

42.57%

N/A

Free Cash Flow

$148.29K

+29.0%

Operating Cash Flow

$148.29K

+29.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
KLDOKaleido Biosciences, Inc.
$0.00+0.00%
XENOXeno Transplants Corporation
$0.00+0.00%
TNGNQTengion, Inc.
$0.00+0.00%
BTTXBetter Therapeutics, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$42.97-0.06%
ANNAAleAnna
$6.98+0.84%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.77+0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.12-0.07%

Questions About IVBT

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.